WallStSmart

Uipath Inc (PATH)vsVuzix Corp Cmn Stk (VUZI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Uipath Inc generates 27356% more annual revenue ($1.67B vs $6.09M). PATH leads profitability with a 19.6% profit margin vs 0.0%. PATH earns a higher WallStSmart Score of 71/100 (B).

PATH

Strong Buy

71

out of 100

Grade: B

Growth: 8.7Profit: 6.0Value: 7.7Quality: 7.5
Piotroski: 5/9Altman Z: 1.50

VUZI

Avoid

16

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -11.94
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for PATH.

VUZIUndervalued (+40.3%)

Margin of Safety

+40.3%

Fair Value

$4.14

Current Price

$4.23

$0.09 discount

UndervaluedFair: $4.14Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PATH6 strengths · Avg: 9.0/10
PEG RatioValuation
0.3810/10

Growing faster than its price suggests

EPS GrowthGrowth
105.7%10/10

Earnings expanding 105.7% YoY

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

P/E RatioValuation
17.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
17.3%8/10

17.3% revenue growth

VUZI1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Areas to Watch

PATH1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

VUZI4 concerns · Avg: 3.5/10
Price/BookValuation
14.1x4/10

Trading at 14.1x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$259.45M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : PATH

The strongest argument for PATH centers on PEG Ratio, EPS Growth, Debt/Equity. Profitability is solid with margins at 19.6% and operating margin at 7.3%. Revenue growth of 17.3% demonstrates continued momentum.

Bull Case : VUZI

The strongest argument for VUZI centers on Debt/Equity.

Bear Case : PATH

The primary concerns for PATH are Altman Z-Score.

Bear Case : VUZI

The primary concerns for VUZI are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

PATH profiles as a growth stock while VUZI is a value play — different risk/reward profiles.

VUZI carries more volatility with a beta of 1.69 — expect wider price swings.

PATH is growing revenue faster at 17.3% — sustainability is the question.

PATH generates stronger free cash flow (129M), providing more financial flexibility.

Bottom Line

PATH scores higher overall (71/100 vs 16/100), backed by strong 19.6% margins and 17.3% revenue growth. VUZI offers better value entry with a 40.3% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Uipath Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

UiPath Inc. provides an end-to-end automation platform offering a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company is headquartered in New York, New York.

Visit Website →

Vuzix Corp Cmn Stk

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.

Want to dig deeper into these stocks?